• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Permethrin Fact Sheet

    PDF Version of this Fact Sheet

    Permethrin is a pyrethroid that can be inhaled, ingested, or absorbed through skin.

    Depending on the formulation, permethrin is a non-toxic to moderately toxic pesticide. Short-term side effects in sensitive individuals include eye, skin, nose, and throat irritation, and may include breathing problems. Signs and symptoms of poisoning following very high exposure include abnormal facial sensation, dizziness, salivation, headache, fatigue, vomiting, diarrhea, and irritability to sound and touch. Pulmonary edema, seizures, and fasciculations may occur in more severe cases. Permethrin DOES NOT cause cholinesterase inhibition. There are no laboratory tests to confirm the presence of permethrin in an individual.

    Toxicological Effects of permethrin*:

    Acute toxicity: Permethrin is moderately to practically non-toxic via the oral route, with a reported LD50 for technical permethrin in rats of 430 to 4000 mg/kg. Via the dermal route, it is slightly toxic, with a reported dermal LD50 in rats of over 4000 mg/kg, and in rabbits of greater 2000 mg/kg. Permethrin caused mild irritation of both the intact and abraded skin of rabbits. It also caused conjunctivitis when it was applied to the eyes The 4-hour inhalation LC50 for rats was greater than 23.5 mg/L, indicating practically no inhalation toxicity. The toxicity of permethrin is dependent on the ratio of the isomers present; the cis-isomer being more toxic.

    Chronic toxicity: No adverse effects were observed in dogs fed permethrin at doses of 5 mg/kg/day for 90 days. Rats fed 150 mg/kg/day for 6 months showed a slight increase in liver weights. Very low levels of permethrin in the diet of chickens (0.1 ppm for 3 to 6 weeks after hatching) have been reported to suppress immune system activity.

    Reproductive effects: The fertility of female rats was affected when they received very high oral doses of 250 mg/kg/day of permethrin during the 6th to 15th day of pregnancy. It is not likely that reproductive effects will be seen in humans under normal circumstances.

    Teratogenic effects: Permethrin is reported to show no teratogenic activity.

    Mutagenic effects: Permethrin is reported to show no mutagenic activity.

    Carcinogenic effects: The evidence regarding the carcinogenicity of permethrin is inconclusive.

    Organ toxicity: Permethrin is suspected of causing liver enlargement of the liver and nerve damage. Effects on the immune system have been noted in animal studies.

    Fate in humans and animals: Permethrin is efficiently metabolized by mammalian livers [40]. Breakdown products, or 'metabolites,' of permethrin are quickly excreted and do not persist significantly in body tissues. When permethrin is administered orally to rats, it is rapidly metabolized and almost completely eliminated from the body in a few days. Only 3 to 6% of the original dose was excreted unchanged in the feces of experimental animals. Permethrin may persist in fatty tissues, with half-lives of 4 to 5 days in brain and body fat. Permethrin does not block, or inhibit, cholinesterase enzymes. For more information about permethrin please contact the National Pesticide Telecommunications Network at 1-800-858-7378 *most studies quoted were conducted exclusively in animals

    This information has been taken directly from the following sources:

    • City Health Information, 'A West Nile Virus Supplement', The New York City Department of Health, June 2000, v19 s1.
    • Extoxnet, Extension Toxicology Network, 'Pesticide Information Profiles'. Website address:http://ace.orst.edu/cgi-bin/mfs/01/pips/permethr.htm
    • Information distributed previously by The Baltimore City Health Department Note: for information about all numbered references in this document, please see the following website:http://ace.orst.edu/cgi-bin/mfs/01/pips/reflist2.htm